User profiles for Santos Mañes
Santos MañesProf of molecular immunology. Spanish Research Council Verified email at cnb.csic.es Cited by 10186 |
Pathogens: raft hijackers
Throughout evolution, organisms have developed immune-surveillance networks to protect
themselves from potential pathogens. At the cellular level, the signalling events that regulate …
themselves from potential pathogens. At the cellular level, the signalling events that regulate …
Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization
…, I Illa, A Bernad, S Mañes… - Proceedings of the …, 2001 - National Acad Sciences
Redistribution of specialized molecules in migrating cells develops asymmetry between two
opposite cell poles, the leading edge and the uropod. We show that acquisition of a motile …
opposite cell poles, the leading edge and the uropod. We show that acquisition of a motile …
Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation
…, JM Rodríguez-Frade, S Mañes… - Annual review of …, 2001 - annualreviews.org
A broad array of biological responses, including cell polarization, movement, immune and
inflammatory responses, and prevention of HIV-1 infection, are triggered by the chemokines, a …
inflammatory responses, and prevention of HIV-1 infection, are triggered by the chemokines, a …
[HTML][HTML] Membrane raft microdomains mediate lateral assemblies required for HIV‐1 infection
S Mañes, G del Real, RA Lacalle, P Lucas… - EMBO …, 2000 - embopress.org
HIV‐1 infection triggers lateral membrane diffusion following interaction of the viral envelope
with cell surface receptors. We show that these membrane changes are necessary for …
with cell surface receptors. We show that these membrane changes are necessary for …
T cell costimulation by chemokine receptors
Signals mediated by chemokine receptors may compete with T cell receptor stop signals
and determine the duration of T cell–antigen-presenting cell interactions. Here we show that …
and determine the duration of T cell–antigen-presenting cell interactions. Here we show that …
Statins inhibit HIV-1 infection by down-regulating Rho activity
…, M Alvarez-Mon, C Martínez-A, S Mañes - The Journal of …, 2004 - rupress.org
Human immunodeficiency virus (HIV)-1 infectivity requires actin-dependent clustering of
host lipid raft–associated receptors, a process that might be linked to Rho guanosine …
host lipid raft–associated receptors, a process that might be linked to Rho guanosine …
Orchestration of lymphocyte chemotaxis by mitochondrial dynamics
S Campello, RA Lacalle, M Bettella, S Mañes… - The Journal of …, 2006 - rupress.org
Lymphocyte traffic is required to maintain homeostasis and perform appropriate immunological
reactions. To migrate into inflamed tissues, lymphocytes must acquire spatial and …
reactions. To migrate into inflamed tissues, lymphocytes must acquire spatial and …
[HTML][HTML] The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism
The discoidin domain receptor 2 (DDR2) is a member of a subfamily of receptor tyrosine
kinases whose ligands are fibrillar collagens, and is widely expressed in postnatal tissues. We …
kinases whose ligands are fibrillar collagens, and is widely expressed in postnatal tissues. We …
[HTML][HTML] Membrane raft microdomains mediate front–rear polarity in migrating cells
S Mañes, E Mira, C Gómez‐Moutón, RA Lacalle… - The EMBO …, 1999 - embopress.org
The acquisition of spatial and functional asymmetry between the rear and the front of the cell
is a necessary step for cell chemotaxis. Insulin‐like growth factor‐I (IGF‐I) stimulation of the …
is a necessary step for cell chemotaxis. Insulin‐like growth factor‐I (IGF‐I) stimulation of the …
[HTML][HTML] Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Background ErbB2-positive breast cancer is characterized by highly aggressive phenotypes
and reduced responsiveness to standard therapies. Although specific ErbB2-targeted …
and reduced responsiveness to standard therapies. Although specific ErbB2-targeted …